{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:34:29Z","timestamp":1767987269652,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001254","name":"Ipsen Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clinthera.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T17:07:23Z","timestamp":1570727243000},"page":"2321-2330.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses"],"prefix":"10.1016","volume":"41","author":[{"given":"Carlo","family":"Colosimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roongroj","family":"Bhidayasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klemens","family":"Fheodoroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Mo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Landreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Jorge","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.09.007_bib1","first-page":"2201","article-title":"Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement","volume":"262","author":"Albanese","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2019.09.007_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1468-1331.2010.03045.x","article-title":"Craniocervical dystonia: clinical and pathophysiological features","volume":"17","author":"Colosimo","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2019.09.007_bib3","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2340\/16501977-0885","article-title":"Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity","volume":"43","author":"Baguley","year":"2011","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.clinthera.2019.09.007_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.clinthera.2019.09.007_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2340\/16501977-0009","article-title":"Are clinical characteristics associated with upper-extremity hypertonia in severe ischaemic supratentorial stroke?","volume":"39","author":"van Kuijk","year":"2007","journal-title":"J\u00a0Rehabil Med"},{"issue":"15","key":"10.1016\/j.clinthera.2019.09.007_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3109\/09638288.2015.1106592","article-title":"Trajectories of Outcome in Neurological Conditions (TONiC) study. Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions","volume":"38","author":"Milinis","year":"2016","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.clinthera.2019.09.007_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1191\/0269215505cr827oa","article-title":"A\u00a0randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury","volume":"19","author":"Verplancke","year":"2005","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2019.09.007_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-007-0833-2","article-title":"Spasticity treatment with botulinum toxins","volume":"115","author":"Ward","year":"2008","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.clinthera.2019.09.007_bib9","author":"Royal College of Physicians"},{"key":"10.1016\/j.clinthera.2019.09.007_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mdc3.12172","article-title":"Selection of muscles for botulinum toxin injections in cervical dystonia","volume":"2","author":"Jost","year":"2015","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.clinthera.2019.09.007_bib11","first-page":"837","article-title":"An international survey of patients with cervical dystonia","volume":"262","author":"Comella","year":"2015","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.clinthera.2019.09.007_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2013.08.028","article-title":"How long does it take to diagnose cervical dystonia?","volume":"335","author":"Tiderington","year":"2013","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.clinthera.2019.09.007_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2019.09.007_bib14","article-title":"Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management","volume":"3","author":"Turner-Stokes","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2019.09.007_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0269215516655589","article-title":"Does the method of botulinum neurotoxin injection for limb spasticity affect outcomes? A systematic review","volume":"31","author":"Chan","year":"2017","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.clinthera.2019.09.007_bib18","author":"Cofemer"},{"issue":"2","key":"10.1016\/j.clinthera.2019.09.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.11138\/FNeur\/2017.32.2.103","article-title":"Ixcellence Network\u00ae: an international educational network to improve current practice in the management of cervical dystonia or spastic paresis by botulinum toxin injection","volume":"32","author":"Fheodoroff","year":"2017","journal-title":"Funct Neurol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819304849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:47Z","timestamp":1758963047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819304849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0149291819304849"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.09.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Spastic Paresis and Cervical Dystonia: Access to Therapeutic Innovations Through an International Program of Practical Courses","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}